Rising Occurrence Of Genetic Disorders Fueling The Growth Of The Market Due To Advanced Parental Age And Gene Therapy Demand: Critical Driver Shaping the Global Viral Vector Production (Research-Use) Market in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Viral Vector Production (Research-Use) Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for viral vector production for research purposes has seen quick expansion in recent years. It is projected to rise from $1.54 billion in 2024 to $1.77 billion in 2025, with a compound annual growth rate (CAGR) of 15.4%. This significant growth during the historic period can be linked to advancements in basic genetic and cell biology research, an increase in research focused on infectious diseases, the extensive use of viral vectors for CRISPR and RNAi studies, heightened demands due to cancer immunotherapy studies, and burgeoning academic interest coupled with initial clinical trials in gene therapy.

Viral Vector Production (Research-Use) Market Size Forecast: What's the Projected Valuation by 2029?
The market size for viral vector production for research use is projected to experience a significant surge in the coming years. It is anticipated to expand to $3.10 billion by 2029, with a compound annual growth rate (CAGR) of 15.0%. This anticipated growth during the predicted period can be ascribed to factors such as the escalating prevalence of genetic disorders, an expanding preclinical gene therapy pipeline, increasing usage in studies of regenerative medicine, surging research into neurodegenerative diseases, and heightening levels of funding for rare disease research. The forecast period is also expected to witness notable trends including advancements in gene therapy research, automation in vector quality control (QC), development of hybrid and chimeric vectors, automation in upstream and downstream processes, and modifications in synthetic biology-based vector.

View the full report here:
https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

What Are the Drivers Transforming the Viral Vector Production (Research-Use) Market?
The increase in genetic disorders is anticipated to stimulate the expansion of the viral vector production (research-use) market in the foreseeable future. Genetic disorders, diseases or conditions caused by irregularities in a person's DNA, can be inherited from parents or arise from fresh genetic mutations. The increment in genetic disorders is because of the rising age of parents, consequently heightening the probability of genetic mutations transmitted to children. The escalation in the incidence of genetic disorders promotes the growth of viral vector production (research-use) through escalating the need for superior gene delivery means to examine disease procedures and establish possible therapy methods. For example, as per the US-based government public health agency CDC in November 2024, Trisomy 21 (Down syndrome) is seen in around 1 in 643 births, resulting in nearly 5,713 new instances yearly, while Trisomy 18 is seen in about 1 in 3,336 births, or approximately 1,101 cases annually. Hence, the upsurge in genetic disorders is predicted to stimulate the expansion of the viral vector production (research-use) market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

What Long-Term Trends Will Define the Future of the Viral Vector Production (Research-Use) Market?
Major corporations in the viral vector production market are concentrating their efforts on creating enhanced solutions such as specialized cell culture media. The aim is to augment transfection efficacy, boost viral vector outputs, and maintain consistent quality for research uses. Cell culture media are brimming with nutrients devised to maintain and boost the growth of cells outside their typical environment, with crucial components such as amino acids, vitamins, and growth factors tailored for certain cell types and applications. For example, FUJIFILM Irvine Scientific, a US life science company, in January 2023 unveiled a breakthrough product, the BalanCD HEK293 Viral Feed. It has been recognized as the first-ever chemically defined nutrient feed specifically enhanced for HEK293 suspension cultures employed in AAV viral vector production. This introduction has the potential to substantially enhance adeno-associated virus (AAV) yields with up to 67% betterment in viral packaging productivity in comparison to basal media. This feed is engineered to fit gene therapy and biotech workflows seamlessly, while ensuring reliable performance across different formats and aligning with several media systems.

Which Segments in the Viral Vector Production (Research-Use) Market Offer the Most Profit Potential?
The viral vector production (research-use) market covered in this report is segmented as

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types
2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods
3) By Workflow: Upstream Processing, Downstream Processing
4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications
5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:
1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus
2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus
3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus
4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus
5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28350&type=smp

Which Firms Dominate the Viral Vector Production (Research-Use) Market by Market Share and Revenue in 2025?
Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton, dic*kinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, and Mustang Bio Inc.

Which Regions Offer the Highest Growth Potential in the Viral Vector Production (Research-Use) Market?
North America was the largest region in the virtual vector production (research-use) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral vector production (research-use) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28350

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.